Literature DB >> 16983089

Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis.

Jiang Chang1, Min Xie, Viraj R Shah, Michael D Schneider, Mark L Entman, Lei Wei, Robert J Schwartz.   

Abstract

Rho-associated coiled-coil protein kinase 1 (ROCK-1) is a direct cleavage substrate of activated caspase-3, which is associated with heart failure. In the course of human heart failure, we found marked cleavage of ROCK-1 resulting in a 130-kDa subspecies, which was absent in normal hearts and in an equivalent cohort of patients with left ventricular assist devices. Murine cardiomyocytes treated with doxorubicin led to enhanced ROCK-1 cleavage and apoptosis, all of which was blocked by a caspase-3 inhibitor. In addition, a bitransgenic mouse model of severe cardiomyopathy, which overexpresses Gq protein and hematopoietic progenitor kinase-/germinal center kinase-like kinase, revealed the robust accumulation of the 130-kDa ROCK-1 cleaved fragment. This constitutively active ROCK-1 subspecies, when expressed in cardiomyocytes, led to caspase-3 activation, indicating a positive feed-forward regulatory loop. ROCK-1-dependent caspase-3 activation was coupled with the activation of PTEN and the subsequent inhibition of protein kinase B (Akt) activity, all of which was attenuated by siRNA directed against ROCK-1 expression. Similarly, ROCK-1-null mice (Rock-1(-/-)) showed a marked reduction in myocyte apoptosis associated with pressure overload. These data suggest an obligatory role for ROCK-1 cleavage in promoting apoptotic signals in myocardial hypertrophy and/or failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16983089      PMCID: PMC1599988          DOI: 10.1073/pnas.0601911103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Regulation and functions of Rho-associated kinase.

Authors:  M Amano; Y Fukata; K Kaibuchi
Journal:  Exp Cell Res       Date:  2000-11-25       Impact factor: 3.905

2.  Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.

Authors:  T Ishizaki; M Uehata; I Tamechika; J Keel; K Nonomura; M Maekawa; S Narumiya
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

Review 3.  Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes.

Authors:  J Narula; E Arbustini; Y Chandrashekhar; M Schwaiger
Journal:  Cardiol Clin       Date:  2001-02       Impact factor: 2.213

4.  Galpha11 induces caspase-mediated proteolytic activation of Rho-associated kinase, ROCK-I, in HeLa cells.

Authors:  H Ueda; R Morishita; H Itoh; S Narumiya; K Mikoshiba; K Kato; T Asano
Journal:  J Biol Chem       Date:  2001-09-06       Impact factor: 5.157

5.  Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis.

Authors:  Ying-Min Zhang; Jacqueline Bo; George E Taffet; Jiang Chang; Jianjian Shi; Anilkumar K Reddy; Lloyd H Michael; Michael D Schneider; Mark L Entman; Robert J Schwartz; Lei Wei
Journal:  FASEB J       Date:  2006-05       Impact factor: 5.191

6.  Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice.

Authors:  Yoshiyuki Rikitake; Naotsugu Oyama; Chao-Yung C Wang; Kensuke Noma; Minoru Satoh; Hyung-Hwan Kim; James K Liao
Journal:  Circulation       Date:  2005-10-31       Impact factor: 29.690

7.  Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I.

Authors:  M L Coleman; E A Sahai; M Yeo; M Bosch; A Dewar; M F Olson
Journal:  Nat Cell Biol       Date:  2001-04       Impact factor: 28.824

8.  Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing.

Authors:  M Sebbagh; C Renvoizé; J Hamelin; N Riché; J Bertoglio; J Bréard
Journal:  Nat Cell Biol       Date:  2001-04       Impact factor: 28.824

9.  Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer.

Authors:  S F Shariat; S Desai; W Song; T Khan; J Zhao; C Nguyen; B A Foster; N Greenberg; D M Spencer; K M Slawin
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

10.  The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival.

Authors:  G Schwartzbauer; J Robbins
Journal:  J Biol Chem       Date:  2001-07-11       Impact factor: 5.157

View more
  106 in total

Review 1.  Pathophysiological Functions of Rnd3/RhoE.

Authors:  Wei Jie; Kelsey C Andrade; Xi Lin; Xiangsheng Yang; Xiaojing Yue; Jiang Chang
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

2.  Mechanism of fibrotic cardiomyopathy in mice expressing truncated Rho-associated coiled-coil protein kinase 1.

Authors:  Xiangsheng Yang; Qi Li; Xi Lin; Yanlin Ma; Xiaojing Yue; Zhenyin Tao; Fen Wang; Wallace L Mckeehan; Lei Wei; Robert J Schwartz; Jiang Chang
Journal:  FASEB J       Date:  2012-01-25       Impact factor: 5.191

3.  SHP-2 acts via ROCK to regulate the cardiac actin cytoskeleton.

Authors:  Yvette Langdon; Panna Tandon; Erika Paden; Jennifer Duddy; Joan M Taylor; Frank L Conlon
Journal:  Development       Date:  2012-01-25       Impact factor: 6.868

4.  RhoE is a pro-survival p53 target gene that inhibits ROCK I-mediated apoptosis in response to genotoxic stress.

Authors:  Pat P Ongusaha; Hyung-Gu Kim; Sarah A Boswell; Anne J Ridley; Channing J Der; G Paolo Dotto; Young-Bum Kim; Stuart A Aaronson; Sam W Lee
Journal:  Curr Biol       Date:  2006-12-19       Impact factor: 10.834

5.  Pharmacological inhibition of Rho-kinase (ROCK) signaling enhances cisplatin resistance in neuroblastoma cells.

Authors:  Catharine A Street; Alissa A Routhier; Carrie Spencer; Ashley L Perkins; Katherine Masterjohn; Alexander Hackathorn; John Montalvo; Emily A Dennstedt; Brad A Bryan
Journal:  Int J Oncol       Date:  2010-11       Impact factor: 5.650

Review 6.  Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension.

Authors:  M Oka; K A Fagan; P L Jones; I F McMurtry
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

Review 7.  Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.

Authors:  Naoki Sawada; James K Liao
Journal:  Antioxid Redox Signal       Date:  2013-09-24       Impact factor: 8.401

Review 8.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

9.  Changes in cardiac Na+/K+-ATPase expression and activity in female rats fed a high-fat diet.

Authors:  Aleksandra Jovanovic; Milan Obradovic; Emina Sudar Milovanovic; Alan J Stewart; Samantha J Pitt; Dragan Alavantic; Ema Aleksic; Esma R Isenovic
Journal:  Mol Cell Biochem       Date:  2017-05-31       Impact factor: 3.396

10.  ROCK1 inhibitor stabilizes E-cadherin and improves barrier function in experimental necrotizing enterocolitis.

Authors:  Christie Buonpane; Carrie Yuan; Douglas Wood; Guillermo Ares; Samuel C Klonoski; Catherine J Hunter
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-02-24       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.